Product image of Levetiracetam Altan (Levetiracetam) supplied by GNH India

Levetiracetam Altan

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Altan (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Altan, is an antiepileptic presented as an intravenous formulation for intravenous use. It is indicated for the treatment of partial‑onset seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients who require rapid or controlled drug delivery. The product complies with European Union regulatory standards and is manufactured under GMP conditions.

GNH India supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Altan Pharmaceuticals S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam Altan is an antiepileptic drug used to control seizure activity across several seizure types.
  • Partial‑onset seizures: reduces frequency and severity of focal seizures.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes.
  • Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic transmission, stabilizing neuronal firing and decreasing hyperexcitability in the central nervous system, which contributes to seizure control without directly affecting ion channels or GABA receptors.

Side Effects

Levetiracetam Altan may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Fatigue: mild to moderate tiredness.
  • Dizziness: transient sensation of light‑headedness.
  • Headache: occasional throbbing pain.
  • Nausea: mild gastrointestinal upset.
  • Irritability: mood changes or agitation.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Mood disorders: depression or suicidal thoughts.
  • Hematologic abnormalities: low blood cell counts.
  • Hepatic dysfunction: elevated liver enzymes.
  • Respiratory depression: especially when combined with other CNS depressants.

Precautions & Warnings

  • Before initiating therapy with Levetiracetam Altan, clinicians should consider several safety factors.
  • Renal impairment: adjust dosage or monitor plasma levels.
  • Hepatic impairment: evaluate liver function regularly.
  • Pregnancy: risk unknown; weigh benefits against potential fetal exposure.
  • Concomitant CNS depressants: use with caution due to additive sedation.
  • Behavioral changes: monitor for mood swings or aggression.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Levetiracetam Altan can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma concentrations.
  • Strong enzyme inducers (phenytoin, phenobarbital): can lower drug levels.
  • Alcohol: increased risk of CNS depression.

Moderate Interactions (Monitor Closely)

  • Valproate: may increase adverse effect profile.
  • Antidepressants (SSRIs, SNRIs): watch for enhanced sedation.
  • Other antiepileptics (lamotrigine, topiramate): adjust monitoring as needed.

Frequently Asked Questions

Levetiracetam Altan is prescribed to manage partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It is used in patients who need rapid or controlled intravenous administration, typically in hospital or emergency settings.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces hyperexcitability, helping to prevent the abnormal electrical activity that leads to seizures.

The specific dose of Levetiracetam Altan is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage regimens are individualized and should follow the prescriber’s instructions.

The safety of Levetiracetam Altan in pregnancy and lactation has not been fully established. Clinicians must weigh potential benefits against unknown risks and consider alternative therapies when possible.

To request Levetiracetam Altan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It generally has fewer drug‑enzyme interactions, a rapid onset when given intravenously, and a favorable tolerability profile compared with many older antiepileptics.

Levetiracetam Altan should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability.

Levetiracetam Altan is administered intravenously by a healthcare professional. The infusion rate and volume are set according to the prescriber’s order, typically over a short period to achieve rapid therapeutic levels.

Serious risks include severe allergic reactions (anaphylaxis), mood disorders such as depression or suicidal thoughts, and hematologic abnormalities like low blood cell counts. Prompt medical attention is required if any of these occur.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid its use. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT